Resolute Advisors’s Eli Lilly LLY Stock Holding History

Resolute Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-382	Closed	-$351K	–	94
2026 Q1	$351K	Buy	+382	New	+$387K	0.15%	52
2025 Q2	–	Sell	-18	Closed	-$14.9K	–	82
2025 Q1	$14.9K	Sell	18 -343	-95%	-$285K	﹤0.01%	75
2024 Q4	$279K	Buy	+361	New	+$299K	0.06%	56
2021 Q4	–	Sell	-171	Closed	-$40K	–	377
2021 Q3	$40K	Hold	171	–	–	0.01%	140
2021 Q2	$39K	Buy	171 +43	+34%	+$8.64K	0.01%	108
2021 Q1	$24K	Buy	+128	New	+$25K	﹤0.01%	132

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Resolute Advisors's LLY Position: Q2 2026 in Review

Resolute Advisors sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 382 shares — an estimated $351K sold.

Resolute Advisors first reported a position in LLY in Q1 2021 and held it in 6 quarters. The position peaked at $351K in Q1 2026. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Resolute Advisors reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Resolute Advisors sold 382 Eli Lilly shares in Q2 2026, an estimated $351K.
Resolute Advisors first reported a position in Eli Lilly in Q1 2021 and held it in 6 quarters.
Resolute Advisors's Eli Lilly position peaked at $351K in Q1 2026.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Resolute Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.